Evidence map›Paper›PMID 38759099›Full record

ArticleClinical infectious diseases : an official publication of the Infectious Diseases Society of America2024

Clinical Presentation, Antimicrobial Resistance, and Treatment Outcomes of Aeromonas Human Infections: A 14-Year Retrospective Study and Comparative Genomics of 2 Isolates From Fatal Cases.

Roberto Pineda-Reyes, Blake H Neil, Joseph Orndorff, Natalie Williams-Bouyer, Michael Netherland, Nur A Hasan, Md Ibrahim Tahashilder, Jian Sha, Ashok K Chopra, David Reynoso

Abstract readComparative Study
In one paragraph

Article in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Article
  2. Twenty-two years ofNew microbes and new infections · 2026
    Article
  3. Article
  4. Aeromonas dhakensis as an emerging invasive pathogen: a case series highlighting distinct carbapenem resistance and diagnostic challenge.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2026
    Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Pathogens (Basel, Switzerland) · 2025
    Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Roberto Pineda-ReyesInfectious Disease Division, University of Texas Medical Branch, Galveston, Texas, USA.ORCID 0000-0001-6242-2952
Blake H NeilDepartment of Microbiology and Immunology, University of Texas Medical Branch, Galveston, Texas, USA.ORCID 0009-0002-8091-0604
Joseph OrndorffDepartment of Internal Medicine, University of Texas Medical Branch, Galveston, Texas, USA.
Natalie Williams-BouyerDepartment of Pathology, University of Texas Medical Branch, Galveston, Texas, USA.
Michael NetherlandEzBiome Inc., Gaithersburg, Maryland, USA.
Nur A HasanEzBiome Inc., Gaithersburg, Maryland, USA.ORCID 0000-0003-0175-8879
Md Ibrahim TahashilderDepartment of Biostatistics and Data Science, School of Public and Population Health, University of Texas Medical Branch, Galveston, Texas, USA.ORCID 0000-0001-8521-1461
Jian ShaDepartment of Microbiology and Immunology, University of Texas Medical Branch, Galveston, Texas, USA.
Ashok K ChopraDepartment of Microbiology and Immunology, University of Texas Medical Branch, Galveston, Texas, USA.
David ReynosoInfectious Disease Division, University of Texas Medical Branch, Galveston, Texas, USA.ORCID 0000-0002-2639-4197

Funding

Underlying mechanisms of necrotizing fasciitis during polymicrobial infectionsR21AI135453 · NIAID · UNIVERSITY OF TEXAS MED BR GALVESTON · PI CHOPRA, ASHOK K · 2018 to 2019
$434k
NIAID NIH HHS R21 AI135453NIH HHS R21 AI135453
6 · The paper itself

Abstract

backgroundAeromonas virulence may not be entirely dependent on the host's immune status. Pathophysiologic determinants of disease progression and severity remain unclear.

methodsOne hundred five patients with Aeromonas infections and 112 isolates were identified, their clinical presentations and outcomes were analyzed, and their antimicrobial resistance (AMR) patterns were assessed. Two isolates (A and B) from fatal cases of Aeromonas dhakensis bacteremia were characterized using whole-genome sequencing. Virulence factor- and AMR-encoding genes from these isolates were compared with a well-characterized diarrheal isolate A. dhakensis SSU and environmental isolate Aeromonas hydrophila American Type Culture Collection_7966T.

resultsSkin and soft tissue infections, traumatic wound infections, sepsis, burns, and intraabdominal infections were common. Diabetes, malignancy, and cirrhosis were frequent comorbidities. Male sex, age ≥ 65 years, hospitalization, burns, and intensive care admission were associated with complicated disease. High rates of AMR to carbapenems and piperacillin-tazobactam were found. Treatment failure was observed in 25.7% of cases. Septic shock and hospital-acquired infections were predictors of treatment failure. All 4 isolates harbored assorted broad-spectrum AMR genes including blaOXA, ampC, cphA, and efflux pumps. Only clinical isolates possessed both polar and lateral flagellar genes, genes for various surface adhesion proteins, type 3 and 6 secretion systems and their effectors, and toxin genes, including exotoxin A. Both isolates A and B were resistant to colistin and harbored the mobile colistin resistance-3 (mcr-3) gene.

conclusionsEmpirical therapy tailored to local antibiograms may facilitate favorable outcomes, while advanced diagnostic methods may aid in identifying correct Aeromonas spp. of significant clinical importance.

Indexed as

AeromonasAnti-Bacterial AgentsGram-Negative Bacterial InfectionsVirulence FactorsAdultAgedAged, 80 and overBacteremiaDrug Resistance, BacterialFemaleGenomicsHumansMaleMicrobial Sensitivity TestsMiddle AgedRetrospective StudiesAnti-Bacterial AgentsVirulence FactorsAeromonasantimicrobial resistancegenomicsretrospective study

Identifiers

PMID38759099
PMCPMC11581697

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.